Latest Derivatives News

Insurance Australia Group Limited has announced a quarterly distribution of AUD 1.5191 per Capital Note 3 security, partially franked at 60%, payable on March 17, 2025.

Insurance Australia Group Limited (IAG) has announced a quarterly dividend of AUD 1.5786 per Capital Note, payable on March 17, 2025, with a 60% franking rate reflecting partial tax credits for investors.

Arena REIT delivered a robust HY2025 performance with statutory net profit soaring 87%, underpinned by strategic acquisitions and development completions. The REIT reaffirmed its FY2025 distribution guidance, signaling confidence in sustained growth amid a strong social infrastructure portfolio.

Citigroup Global Markets Australia announces a fully franked $1.70 dividend for JBH CitiFirst Instalment MINIs, aligning with JBH Ordinary shares’ record date and ex-dividend schedule.

Charter Hall Social Infrastructure REIT has reported a strong turnaround with a statutory profit of $31 million for the half year ended December 31, 2024, reversing last year's loss. Despite a slight dip in operating earnings and distributions, the REIT maintains a stable financial position amid ongoing economic uncertainties.

Reckon Limited posted a modest revenue increase to $54.1 million for FY2024, yet net profit declined by 25.7%, reflecting margin pressures despite operational gains. The company also announced a strategic acquisition aimed at bolstering future growth.

Region Group reports a robust first half of FY25 with $81.8 million net profit and an 8% growth in assets under management, underpinned by stable occupancy and strategic capital recycling.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

CSL Limited posted a robust half-year performance with NPATA rising 5% at constant currency, driven by strong growth in CSL Behring and CSL Vifor despite challenges in its influenza vaccine segment. The company reaffirmed its FY25 guidance, anticipating double-digit earnings growth.

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.

Dexus Convenience Retail REIT (ASX: DXC) reported steady half-year results for 2025, underpinned by active portfolio management and ongoing redevelopment projects. The fund remains on track to meet full-year guidance while enhancing income security and growth potential.

Dexus Convenience Retail REIT reported solid half-year results for FY25, maintaining distribution guidance while enhancing portfolio quality through strategic divestments and commencing a major redevelopment at Glass House Mountains.